At the news
? NEUTRALIMPACT 2/10 144 filed Nov 9, 2026 at 15:20 ET
Sarbani Chaudhuri, an officer of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 4,872 shares of common stock with an approximate market value of $11,335. The shares were acquired via restricted stock vesting on November 5, 2026. The filing notes that the sale includes shares needed to cover a tax obligation from the vesting of an equity award, indicating this is a routine tax-related sale rather than a discretionary portfolio reduction.
- Officer Sarbani Chaudhuri filed Form 144 to sell 4,872 shares of common stock
- Estimated aggregate market value of shares: $11,335.20
- Shares acquired via restricted stock vesting on November 5, 2026
- Sale includes shares to cover tax obligation from vested equity award
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access